PDE4A and COVID-19: Lugnier et al. [12], illustrated those PDEs mainly PDE4 are upregulated in both COVID-19 patients and chronic nicotine cigarette smoking, and linked with COVID-19 severity through upregulation of pulmonary ACE2.